Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Acknowledgment to Reviewers
Volume: 6 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Acknowledgment to Reviewers, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2012; 6 (3) . https://dx.doi.org/10.2174/187221412802481766
DOI https://dx.doi.org/10.2174/187221412802481766 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
1
Related Articles
-
Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles
Current Pharmaceutical Design Impact of Ritonavir, Atazanavir and Their Combination on the CYP3A4 Induction by Efavirenz in Primary Human Hepatocytes
Drug Metabolism Letters Immunosuppression and Post-transplant Hyperglycemia
Current Diabetes Reviews Transition Metals for Conjugation of Polyunsaturated Acids and their Esters
Current Organic Chemistry Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment
Current Medicinal Chemistry Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes
Current Genomics Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
Current Genomics Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione
Mini-Reviews in Medicinal Chemistry Zinc-Permeable Ion Channels: Effects on Intracellular Zinc Dynamics and Potential Physiological/Pathophysiological Significance
Current Medicinal Chemistry The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets New Frontiers in the Therapeutic Approach of Patients with Cardiovascular and Endocrine Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhaled Corticosteroids in COPD: Pros and Cons
Current Drug Targets Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research
Current Cardiology Reviews Combination of Daidzein, Hemin and Bms182874 Halts the Progression of Diabetes-Induced Experimental Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in Synthesis and Medicinal Applications of Compounds Derived from Phthalimide
Current Organic Synthesis Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide
Drug Metabolism Letters The Relationship Between Vitamin D Deficiency and Insulin Resistance in Pregnant Women with Gestational Diabetes
Current Diabetes Reviews